News Chart Perspective Therapeutics, Inc.

Stocks

CATX

US46489V3024

Biotechnology & Medical Research

Market Closed - NYSE 07:00:00 20/10/26 am AEDT			5-day change	1st Jan Change
2.190 ^USD	+0.92%		-13.10%	-20.36%

09/10	Perspective Therapeutics, Inc. Receives Fast Track Designation for PSV359 for Treatment of Adult Patients with Locally Advanced Unresectable And/Or Metastatic FAP-Positive Solitary Fibrous Tumors	CI
08/10	Perspective's Cancer Therapy Candidate Receives FDA Fast Track Designation; Shares Rise Pre-Bell	MT

fbf7a7f224daeae5da6e22d0e9472baa.n3JZTiYmEG5_hKTnHxqJ3IByuKpsab193OAUzd2pPhk.-woGHXlxRkMr95bfZ3bP6bUB-tMvK9ctkdhR_LDzeS7SAjYNE1N8Fj3syw~0173067d71c8fa0fdaf56adefd67c254